(2-Hydroxy-3-Methoxybenzylidene)thiazolo[3,2-a]pyrimidines: Synthesis, Self-Assembly in the Crystalline Phase and Cytotoxic Activity. 2023

Artem S Agarkov, and Anna A Nefedova, and Elina R Gabitova, and Dilyara O Mingazhetdinova, and Alexander S Ovsyannikov, and Daut R Islamov, and Syumbelya K Amerhanova, and Anna P Lyubina, and Alexandra D Voloshina, and Igor A Litvinov, and Svetlana E Solovieva, and Igor S Antipin
Arbuzov Institute of Organic and Physical Chemistry, FRC Kazan Scientific Center, Russian Academy of Sciences, Arbuzova 8, 420088 Kazan, Russia.

A series of new 2-hydroxy-3-methoxybenzylidenethiazolo[3,2-a]pyrimidines with different aryl substituents at the 5 position are synthesized and characterized by 1H/ 13C NMR and IR-spectroscopy and mass-spectrometry, as well as single crystal X-ray diffraction (SCXRD). It was demonstrated that the type of hydrogen bonding can play a key role in the chiral discrimination of these compounds in the crystalline phase. The hydrogen bond of the O-H...N type leads to 1D supramolecular heterochiral chains or conglomerate crystallization in the case of the formation of homochiral chains. The hydrogen bond of O-H...O type gave racemic dimers, which are packed into 2D supramolecular layers with a parallel or angular dimers arrangement. Halogen bonding of the N...Br or O...Br type brings a new motif into supramolecular self-assembly in the crystalline phase: the formation of 1D supramolecular homochiral chains instead 2D supramolecular layers. The study of cytotoxicity against various tumor cells in vitro was carried out. It was found that 2-hydroxy-3-methoxybenzylidenethiazolo[3,2-a]pyrimidines with 3-nitrophenyl substituent at C5 carbon atom demonstrated a high efficiency against M-HeLa (cervical adenocarcinoma) and low cytotoxicity against normal liver cells.

UI MeSH Term Description Entries
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D018360 Crystallography, X-Ray The study of crystal structure using X-RAY DIFFRACTION techniques. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) X-Ray Crystallography,Crystallography, X Ray,Crystallography, Xray,X Ray Crystallography,Xray Crystallography,Crystallographies, X Ray,X Ray Crystallographies

Related Publications

Artem S Agarkov, and Anna A Nefedova, and Elina R Gabitova, and Dilyara O Mingazhetdinova, and Alexander S Ovsyannikov, and Daut R Islamov, and Syumbelya K Amerhanova, and Anna P Lyubina, and Alexandra D Voloshina, and Igor A Litvinov, and Svetlana E Solovieva, and Igor S Antipin
January 2020, Beilstein journal of organic chemistry,
Artem S Agarkov, and Anna A Nefedova, and Elina R Gabitova, and Dilyara O Mingazhetdinova, and Alexander S Ovsyannikov, and Daut R Islamov, and Syumbelya K Amerhanova, and Anna P Lyubina, and Alexandra D Voloshina, and Igor A Litvinov, and Svetlana E Solovieva, and Igor S Antipin
June 1998, Archiv der Pharmazie,
Artem S Agarkov, and Anna A Nefedova, and Elina R Gabitova, and Dilyara O Mingazhetdinova, and Alexander S Ovsyannikov, and Daut R Islamov, and Syumbelya K Amerhanova, and Anna P Lyubina, and Alexandra D Voloshina, and Igor A Litvinov, and Svetlana E Solovieva, and Igor S Antipin
October 2017, Bioorganic chemistry,
Artem S Agarkov, and Anna A Nefedova, and Elina R Gabitova, and Dilyara O Mingazhetdinova, and Alexander S Ovsyannikov, and Daut R Islamov, and Syumbelya K Amerhanova, and Anna P Lyubina, and Alexandra D Voloshina, and Igor A Litvinov, and Svetlana E Solovieva, and Igor S Antipin
January 2020, RSC advances,
Artem S Agarkov, and Anna A Nefedova, and Elina R Gabitova, and Dilyara O Mingazhetdinova, and Alexander S Ovsyannikov, and Daut R Islamov, and Syumbelya K Amerhanova, and Anna P Lyubina, and Alexandra D Voloshina, and Igor A Litvinov, and Svetlana E Solovieva, and Igor S Antipin
October 2005, Bioorganic & medicinal chemistry,
Artem S Agarkov, and Anna A Nefedova, and Elina R Gabitova, and Dilyara O Mingazhetdinova, and Alexander S Ovsyannikov, and Daut R Islamov, and Syumbelya K Amerhanova, and Anna P Lyubina, and Alexandra D Voloshina, and Igor A Litvinov, and Svetlana E Solovieva, and Igor S Antipin
June 1999, Bioorganic & medicinal chemistry letters,
Artem S Agarkov, and Anna A Nefedova, and Elina R Gabitova, and Dilyara O Mingazhetdinova, and Alexander S Ovsyannikov, and Daut R Islamov, and Syumbelya K Amerhanova, and Anna P Lyubina, and Alexandra D Voloshina, and Igor A Litvinov, and Svetlana E Solovieva, and Igor S Antipin
July 1998, Yao xue xue bao = Acta pharmaceutica Sinica,
Artem S Agarkov, and Anna A Nefedova, and Elina R Gabitova, and Dilyara O Mingazhetdinova, and Alexander S Ovsyannikov, and Daut R Islamov, and Syumbelya K Amerhanova, and Anna P Lyubina, and Alexandra D Voloshina, and Igor A Litvinov, and Svetlana E Solovieva, and Igor S Antipin
June 2019, Molecules (Basel, Switzerland),
Artem S Agarkov, and Anna A Nefedova, and Elina R Gabitova, and Dilyara O Mingazhetdinova, and Alexander S Ovsyannikov, and Daut R Islamov, and Syumbelya K Amerhanova, and Anna P Lyubina, and Alexandra D Voloshina, and Igor A Litvinov, and Svetlana E Solovieva, and Igor S Antipin
December 2023, Journal of enzyme inhibition and medicinal chemistry,
Artem S Agarkov, and Anna A Nefedova, and Elina R Gabitova, and Dilyara O Mingazhetdinova, and Alexander S Ovsyannikov, and Daut R Islamov, and Syumbelya K Amerhanova, and Anna P Lyubina, and Alexandra D Voloshina, and Igor A Litvinov, and Svetlana E Solovieva, and Igor S Antipin
August 1983, Archiv der Pharmazie,
Copied contents to your clipboard!